⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18030857 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL11605392 | 0.97 | — | — | |
| SCHEMBL310765 | 0.80 | — | — | |
| SCHEMBL2094845 | 0.77 | — | — | |
| SCHEMBL26315380 | 0.77 | TSHR (0.31) | — | |
| SCHEMBL30476272 | 0.77 | HSD17B10 (0.52) | — | |
| SCHEMBL2097809 | 0.77 | ALDH1A1 (0.39) | — | |
| SCHEMBL15826906 | 0.76 | — | — | |
| SCHEMBL11933048 | 0.76 | — | — | |
| SCHEMBL21645160 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026103740-A1 | CEACAM5-ANTIGEN-TARGETING ANTIBODY, ANTIBODY-DRUG CONJUGATE THEREOF AND USE THEREOF | 信达生物医药科技(杭州)有限公司 | 2026-05-21 | — | — | WO | disclosed |
| CN-120019075-A | Antibody drug conjugates targeting C-MET and methods of use | 酵活英属哥伦比亚有限公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-114025795-B | Methods of treating biliary tract cancer using bispecific antigen binding constructs that target HER2 | 酵活英属哥伦比亚有限公司 | 2025-04-29 | — | — | CN | disclosed |
| CN-119306732-B | Bioactive substance conjugate, preparation method and application thereof | 四川科伦博泰生物医药股份有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-113453724-B | Sulfonylmaleimide-based linkers and corresponding conjugates | 皮埃尔法布雷医药公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-113683622-B | Bioactive substance conjugate, preparation method and application thereof | 四川科伦博泰生物医药股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119306732-A | Bioactive substance conjugate, preparation method and application thereof | 四川科伦博泰生物医药股份有限公司 | 2025-01-14 | — | — | CN | disclosed |
| CN-114230664-B | Anti-C10 ORF54 antibodies and uses thereof | 皮埃尔法布雷医药公司 | 2025-01-03 | — | — | CN | disclosed |
| CN-119241554-A | Bioactive substance conjugate, preparation method and application thereof | 四川科伦博泰生物医药股份有限公司 | 2025-01-03 | — | — | CN | disclosed |
| CN-119219654-A | Bioactive substance conjugate, preparation method and application thereof | 四川科伦博泰生物医药股份有限公司 | 2024-12-31 | — | — | CN | disclosed |
| WO-2013170112-A1 | NAMPT INHIBITORS | ABBVIE INC. (US) | 2013-11-14 | — | — | WO | disclosed |
| US-8183338-B2 | Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof | NEKTAR THERAPEUTICS (US) | 2012-05-22 | — | — | US | disclosed |
| US-8163753-B2 | 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| EP-2334636-A2 | HYDROXAMIC ACID DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS | Pfizer Inc. (US) | 2011-06-22 | — | — | EP | disclosed |
| WO-2010032147-A2 | HYDROXAMIC ACID DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS | PFIZER INC. (US) | 2010-03-25 | — | — | WO | disclosed |
| EP-1678185-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMA CO LTD (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | OTSUKA PHAMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| US-4528350-A | Polymers of α,β-unsaturated N-substituted carboxylic acid amides | CHEMISCHE FABRIK STOCKHAUSEN & CIE (DE) | 1985-07-09 | — | — | US | disclosed |
| US-4408073-A | TRANSAMIDATION OF 3-HYDROXY AMIDE, DEHYDRATION | CHEMISCHE FABRIK STOCKHAUSEN & CIE (DE) | 1983-10-04 | — | — | US | disclosed |
| US-4237067-A | REACTING SUBSTITUTED AMIDES WITH AN AMINE AND HEATING IN PRESCENCE OF A CATALYST | CHEMISCHE FABRIK STOCKHAUSEN & CIE. (DE) | 1980-12-02 | — | — | US | disclosed |